Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes

被引:0
|
作者
Patel, S. [1 ]
Weber, S. [2 ]
Emser, A. [2 ]
von Eynatten, M. [2 ]
Woerle, H. -J. [2 ]
机构
[1] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[2] Boehringer Ingelheim KG, D-6507 Ingelheim, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
832
引用
收藏
页码:S339 / S339
页数:1
相关论文
共 50 条
  • [31] Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes
    Hagelberg, A.
    Ivert, T.
    Efendic, S.
    Ohrvik, J.
    Anderson, R. E.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2008, 42 (01) : 71 - 76
  • [32] Are older patients with type 2 diabetes and insulin therapy under worse glycaemic control?
    Hartung, V.
    Reise, K.
    Kloos, C.
    Keil, S.
    Kwetkat, A.
    Lehmann, T.
    Wolf, G.
    Mueller, U. A.
    DIABETOLOGIA, 2011, 54 : S263 - S263
  • [33] Improving glycaemic control in patients with Type 2 diabetes mellitus without insulin therapy
    Goudswaard, AN
    Stolk, RP
    de Valk, HW
    Rutten, GEHM
    DIABETIC MEDICINE, 2003, 20 (07) : 540 - 544
  • [34] Mechanisms by which rosiglitazone improves glycaemic control in Type 2 diabetes
    Gerich, J
    Dostou, J
    Islam, N
    Meyer, C
    Woerle, HJ
    Sparks, C
    Sparks, J
    Wittlin, S
    Dabiri, G
    Anderson, A
    DIABETOLOGIA, 2001, 44 : A201 - A201
  • [35] Basal insulin initiation on the top of metformin improves glycaemic control and safety in Chinese insulin-naive patients with type 2 diabetes
    Zhang, H.
    Zhang, P.
    Luo, Y.
    Zhu, D.
    Li, X.
    Ji, J.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S441 - S442
  • [36] Miglitol combined with metformin improves glycaemic control in type 2 diabetes
    Van Gaal, L
    Maislos, M
    Schernthaner, G
    Rybka, J
    Segal, P
    DIABETES OBESITY & METABOLISM, 2001, 3 (05): : 326 - 331
  • [37] Pioglitazone reduces insulin requirements and improves glycaemic control in insulin-treated patients with type 2 diabetes: results from PROactive
    Schmitz, O.
    Charbonnel, B.
    Scheen, A.
    DIABETOLOGIA, 2006, 49 : 489 - 489
  • [39] Insulin glargine-based therapy improves glycaemic control in patients with type 2 diabetes suboptimally controlled on premixed insulin therapies
    Storms, F.
    Davies, M.
    Gomis, R.
    DIABETOLOGIA, 2006, 49 : 600 - 601
  • [40] Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial
    Torimoto, Keiichi
    Okada, Yosuke
    Goshima, Yukiko
    Tokutsu, Akemi
    Sato, Yasunori
    Tanaka, Yoshiya
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2174 - 2179